◇ Physician-supervised protocols◇ Third-party tested · COA on every lot◇ 99%+ verified purity◇ Cold-chain shipping in 48 hours◇ Licensed in 43 states ◇ Physician-supervised protocols◇ Third-party tested · COA on every lot◇ 99%+ verified purity◇ Cold-chain shipping in 48 hours◇ Licensed in 43 states
Home / Formulary / Semax
Back to formulary
Semax — LORIUM lyophilised vial LORIUM · 10 mg LYOPHILISED VIAL
Third-party tested · COA included with every lot
Cognitive ● In stockPrescription required

Semax

Nootropic peptide · SEMAX

Semax is a premium synthetic heptapeptide analogue engineered to deliver profound neuroprotective and nootropic optimization without hormonal activity. By crossing the blood-brain barrier to upregulate vital BDNF signaling, this protocol sharpens cognitive clarity, preserves neural structures, and enhances focus under stress.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. It is dispensed only pursuant to a valid prescription following evaluation by a licensed provider.

Researched effects

Effects observed in the cited literature. Individual results are not guaranteed. Statements have not been evaluated by the FDA.

BDNF Activation

Promotes a powerful increase in vital Brain-Derived Neurotrophic Factors.

Memory Consolidation

Actively optimizes pathways responsible for learning and retention.

Neuroplasticity Support

Accelerates the development of healthy neural pathways.

Cognitive Rise

Elevates expression of vital neurotrophic factors (BDNF/NGF).

Neuro Protection

Safeguards cerebral neurons against oxidative wear.

Pure Action

Delivers potent advantages with zero hormonal side effects.

Mental Focus

Boosts cognitive performance, learning, and memory.

Specifications

ClassNootropic peptide
CAS number80714-61-0
Molar mass751.9 g/mol
Available sizes10 mg
AdministrationPremium subcutaneous or intranasal protocol.
CategoryCognitive
View a sample certificate of analysis →

Clinical references

  1. Kostrvugova, M. M., et al. (2010). Semax Effects on BDNF Expression. Dokl Biol Sci, 434(1).
  2. Asmadiyarov, A. A., et al. (2001). Semax in Ischemic Incidents. Cerebrovasc Dis, 12(3).
  3. Gusev, E. I., et al. (2005). Neuroprotective Therapy with Semax. Neurol Res, 27(4).
  4. Agapov, I. I., et al. (2008). Semax on Memory and Learning. Bull Exp Biol Med, 145(2).
Related

More in Cognitive

View all →